Achillion Pharmaceuticals

$4.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.31 (-6.78%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ACHN and other stocks, options, ETFs, and crypto commission-free!

About ACHN

Achillion Pharmaceuticals, Inc. engages in the discovery and development of small molecule drug therapies for immune system disorders. It offers its propriety platform of potent and specific complement factor D inhibitors for AP-mediated diseases. Read More The company was founded on August 17, 1998 and is headquartered in New Haven, CT.

Employees
56
Headquarters
Blue Bell, Pennsylvania
Founded
1998
Market Cap
595.09M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.31M
High Today
$4.69
Low Today
$4.21
Open Price
$4.69
Volume
1.71M
52 Week High
$5.03
52 Week Low
$1.29

Collections

ACHN Earnings

-$0.17
-$0.15
-$0.14
-$0.12
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 7, Pre-Market

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.